FindTrial
Sign In

Screening of Oral Cancer

LIQUID BIOPSY FOR ORAL CANCER SCREENING USING SUPERHYDROPHOBIC SURFACE ENHANCED RAMAN PLASMONIC DROPLET ASSAY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/07/035059
Enrollment
159
Registered
2021-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Interventions

None listed

Sponsors

Department of Science and Technology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All above 18 years of age and having malignant or benign type of oral cancer are included.

Exclusion criteria

Exclusion criteria: All patients below age 18 are excluded. Also, the subjects having co-morbidity conditions which does not allow biopsy will be excluded.

Design outcomes

Primary

MeasureTime frame
This study focuses on the development of a portable device based on optical SERS spectroscopic technique for the molecular fingerprinting of microliters of diluted saliva for the detecting oral cancer at an earlier stage. The usage of different multivariate statistical analysis tools will be helpful in analyzing the Raman spectroscopic data thereby differentiating them into different sets.Timepoint: 2 years—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Sajan D George

Manipal Academy of Higher Education

sajan.george@manipal.edu7760595726

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026